SBC
SBC Medical Group Holdings Incorporated
SBC's fundamentals are strong: earnings per share grew 45%. At 11x earnings, it's trading above its usual 9.4x. Analysts expect earnings growth.
SBC Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Strong | |
| Strong | |
| Strong |
SBC's profitability, cash flow and balance sheet are currently strong. There isn't enough data to rate its revenue.
SBC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 7.7x | $3.68 | -31% |
| Fair | 9.4x | $4.49 | -16% |
| Expensive | 11x | $5.34 | 0% |
| Current | 11x | $5.34 | — |
| Forward | 11x | $5.34 | — |
Historical ranges are pointers, not guarantees.
SBC's PE is in its expensive range at 11.1x. If earnings grow as analysts expect, today's price would be 10.6x next year's earnings, in its fair range.
SBC Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Stable | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for SBC, with profitability holding steady.
SBC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.51 | +5.3% |
| Q2 2026 | $0.48 | +45% |
SBC's earnings per share have climbed steadily: $0.48 over the past year, up 45% from the year before, and higher year over year every quarter since mid-2026.
SBC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $49.2M | +13% |
| Q1 2026 | $43.1M | -9% |
| Q4 2025 | $39.6M | -11% |
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 39% | +5 points |
| Q1 2026 | 41% | -10 points |
| Q4 2025 | 32% | +22 points |
| Q3 2025 | 37% | N/A |
| Q2 2025 | 34% | N/A |
| Q1 2025 | 51% | N/A |
| Q4 2024 | 11% | N/A |
SBC's operating margin was 39% last quarter, up 5 points from the same quarter a year ago.
SBC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $22.4M | +$31.1M |
| Q1 2026 | $9.1M | +444% |
| Q4 2025 | $51.2M | +$59.1M |
SBC's free cash flow has turned positive again: $62M over the past year, against −$15M the year before.
SBC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | -- |
| 1 year | -0.9% | -930K shares |
SBC has 103M diluted shares, down 0.9% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2025 | — |
| Q3 2025 | $2.6M |
SBC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | -2.1x | Net Cash |
| Q1 2026 | -2.0x | Net Cash |
| Q4 2025 | -1.7x | Net Cash |
| Q3 2025 | -1.7x | Net Cash |
SBC has more cash than debt.
SBC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 68.0 | Neutral |
| Stochastic | 79.6 | Neutral |
SBC's weekly RSI is 68 (neutral) and its Stochastic is 80 (neutral).
SBC PE vs Industrials Sector
| Metric | SBC | Sector median | Relative |
|---|---|---|---|
| PE | 11x | 24x | 54% below |
| PE % | 82 | 64 | 18 pts above |
SBC is trading at 11x earnings, a 54% discount to the Industrials sector's median of 24x.
SBC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $5.19 | 2.9% above |
| 20 week MA | $4.25 | 26% above |
| 50 week MA | $4.01 | 33% above |
| 100 week MA | $4.15 | 29% above |
| 200 week MA | $7.47 | 29% below |
SBC has bounced recently, but its long-term trend is still down: it's above its 8-, 20-, 50- and 100-week averages, but 29% below its 200-week average.
SBC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2022 | $10.0 | $10.2 | +1.3% |
| 2023 | $10.2 | $10.8 | +6.1% |
| 2024 | $10.8 | $5.80 | -46% |
| 2025 | $5.80 | $4.44 | -23% |
| 2026 YTD | $4.44 | $5.34 | +20% |
SBC has finished lower in two of the last four years. It's up 20% so far in 2026.